Araki Takuya 荒木拓也

… Alternative Names

ARAKI TAKUYA 荒木拓也

Less

Researcher Number	00568248
Other IDs
Affiliation (Current)	2025: 群馬大学, 大学院医学系研究科, 准教授
Affiliation (based on the past Project Information) *help	2016 – 2024: 群馬大学, 大学院医学系研究科, 准教授 2013 – 2015: 群馬大学, 医学(系)研究科(研究院), 准教授 2012: 群馬大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy Except Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy
Keywords	Principal Investigator がん / 薬剤抵抗性 / 抗体医薬品 / 抗体医薬 / 耐性 / SRC / 薬物抵抗性 / プロテオーム / 抗腫瘍薬 / 獲得耐性 … More / 化学療法 / 分子標的薬 / DPP4 / インクレチン / LDL受容体 / スルフォニルウレア / DPP-4 / 抵抗性 / インスリン / 二次無効 / バイオマーカー / 抗抗体医薬品抗体 / 成分分析 / 質量分析 / 薬物療法 / 個別化医療 … More Except Principal Investigator 薬動力学解析 / 血小板 / 薬動力学 / プロテオーム解析 / 血液凝固 / Talin / 抗血小板薬 / ＰＫ－ＰＤ解析 / 薬物輸送担体 / PK-PD解析 / 細胞中薬物濃度 / 血中薬物濃度 / 薬力学 / 細胞内薬物動態 / 細胞内薬物濃度 / 薬剤抵抗性 Less

Strategies for Overcoming Acquired Resistance to Molecular Targeted Anti-Tumor Drugs by Modulating SRC-Related FactorsPrincipal Investigator
- Principal Investigator
  
  荒木拓也
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Gunma University
抗血小板薬による血小板凝集抑制作用の生理学的薬物動力学モデルによる解析
- Principal Investigator
  
  山本康次郎
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Gunma University
Establishment of efficacy index and pharmacokinetic analysis of antiplatelet drugs based on proteomic analysis
- Principal Investigator
  
  YAMAMOTO KOUJIROU
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Gunma University
Mechanism of development of resistance to antitumor molecule-targeted drugsPrincipal Investigator
- Principal Investigator
  
  Araki Takuya
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Gunma University
Drug resistance caused by intracellular pharmacokinetics
- Principal Investigator
  
  YAMAMOTO KOUJIROU
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Gunma University
Methods for drug selection and decision of drug administration design of insulin secretagogue based on PK/PD analysisPrincipal Investigator
- Principal Investigator
  
  Araki Takuya
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Gunma University
administration plannning of antibody drugs based on PK/PD analysisPrincipal Investigator
- Principal Investigator
  
  ARAKI TAKUYA
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Gunma University

All 2019 2018 2017 2016 2014 2013 Other

All Journal Article Presentation

[Journal Article] Exploration of proteins involved in acquisition of resistance to cetuximab2019
- Author(s)
  Hironori Nakamura, Ayumu Nagamine, Hideaki Yashima, Takuya Araki, Koujirou Yamamoto
- Journal Title
  
  Indonesian Journal of Pharmaceutics
  
  Volume: 1 Issue: 1 Pages: 11-18
- DOI
  10.24198/idjp.v1i1.19582
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K06743
[Journal Article] L-Lactate dehydrogenase B may be a predictive marker for sensitivity to anti-EGFR monoclonal antibodies in colorectal cancer cell lines2019
- Author(s)
  Ayumu Nagamine, Takuya Araki, Daisuke Nagano, Mitsue Miyazaki, Koujirou Yamamoto
- Journal Title
  
  Oncology letters
  
  Volume: 17 Pages: 4710-4716
- DOI
  10.3892/ol.2019.10075
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K06743
[Journal Article] Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study.2016
- Author(s)
  Kunio Yanagisawa, Daisuke Nagano, Yoshiyuki Ogawa, Hideki Uchiumia, Tetsuya Shigehara, Kazuhisa Saruki, Hiroshi Handa, Takuya Araki, Koujirou Yamamoto, Yoshihisa Nojima
- Journal Title
  
  ＡＩＤＳ
  
  Volume: 30 Issue: 6 Pages: 970-972
- DOI
  10.1097/qad.0000000000001012
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08066
[Presentation] セツキシマブに対する後天的耐性を獲得した大腸癌に対する治療法の探索2019
- Author(s)
  荒木拓也, 中村浩規, 長嶺歩, 八島秀明, 山本康次郎
- Organizer
  第29回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-18K06743
[Presentation] ヒト大腸癌細胞株に対するセツキシマブの効果と LDH 発現量の関係2018
- Author(s)
  長嶺歩，荒木拓也，永野大輔，山本康次郎
- Organizer
  医療薬学フォーラム2018・第26回クリニカルファーマシーシンポジウム
- Data Source
  KAKENHI-PROJECT-18K06743
[Presentation] The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma.2017
- Author(s)
  Daisuke Nagano, Takuya Araki, Kunio Yanagisawa, Yoshiyuki Ogawa, Hideki Uchiumi, Koujirou Yamamoto
- Organizer
  The 13th Congress of the European association for clinical pharmacology and therapeutics (EACPT).
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08066
[Presentation] The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma.2017
- Author(s)
  Daisuke Nagano, Takuya Araki, Kunio Yanagisawa, Yoshiyuki Ogawa, Hideki Uchiumi, Yoshihisa Nojima, Koujirou Yamamoto
- Organizer
  American Society of Clinical Pharmacology and Therapeutics Annual Meeting 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08066
[Presentation] Establishment of method for quantitation of antibody drugs using LC-MS/MS with biomarker analytical technique2014
- Author(s)
  Hironori Nakamura, Takuya Araki, Daisuke Nagano, Koujirou Yamamoto
- Organizer
  6th International Conference on Advanced Micro‐Device Engineering
- Place of Presentation
  Kiryu, Gunma, Japan
- Year and Date
  2014-12-05
- Data Source
  KAKENHI-PROJECT-24790145
[Presentation] Development approach using LC-MS/MS and biomarker analytical technique for the quantification of infliximab in human blood2013
- Author(s)
  Hironori Nakamura, Takuya Araki, Koujirou Yamamoto
- Organizer
  第7回次世代を担う若手医療薬科学シンポジウム
- Place of Presentation
  仙台
- Data Source
  KAKENHI-PROJECT-24790145
[Presentation] LC-MS/MS method for the quantification of infliximab in human blood2013
- Author(s)
  Hironori Nakamura, Takuya Araki, Tomonori Nakamura, Koujirou Yamamoto
- Organizer
  13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT)
- Place of Presentation
  Salt Lake City, USA
- Data Source
  KAKENHI-PROJECT-24790145
[Presentation] Establishment of prediction method for clinical efficacy of antibody drugs using LC-MS/MS with biomarker searching technique
- Author(s)
  Hironori Nakamura, Takuya Araki, Koujirou Yamamoto
- Organizer
  5th InternationalConference on Advanced Micro‐Device Engineering
- Place of Presentation
  Kiryu, Gunma, Japan
- Data Source
  KAKENHI-PROJECT-24790145
[Presentation] Quantification of an antibody drug, infliximab, in human blood using biomarker analysis technique
- Author(s)
  Hironori Nakamura, Takuya Araki, Daisuke Nagano, Koujirou Yamamoto
- Organizer
  International Congress of Therapeutic Drug Monitoring & Clinical Toxicology European Conference
- Place of Presentation
  Prague, Czech Republic
- Year and Date
  2014-08-28 – 2014-08-30
- Data Source
  KAKENHI-PROJECT-24790145

1. YAMAMOTO KOUJIROU (70174787)

# of Collaborated Projects: 6 results

# of Collaborated Products: 12 results
2. 永野大輔 (90738387)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
3. 八島秀明 (60773512)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
4. 坡下真大 (20613384)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 長嶺歩 (00882622)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. NAKAMURA Hironori

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results

Araki Takuya 荒木 拓也

ARAKI TAKUYA 荒木 拓也

Research Projects

Research Products

Co-Researchers

Strategies for Overcoming Acquired Resistance to Molecular Targeted Anti-Tumor Drugs by Modulating SRC-Related FactorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

抗血小板薬による血小板凝集抑制作用の生理学的薬物動力学モデルによる解析

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment of efficacy index and pharmacokinetic analysis of antiplatelet drugs based on proteomic analysis

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of development of resistance to antitumor molecule-targeted drugsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Drug resistance caused by intracellular pharmacokinetics

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Methods for drug selection and decision of drug administration design of insulin secretagogue based on PK/PD analysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

administration plannning of antibody drugs based on PK/PD analysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Exploration of proteins involved in acquisition of resistance to cetuximab2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] L-Lactate dehydrogenase B may be a predictive marker for sensitivity to anti-EGFR monoclonal antibodies in colorectal cancer cell lines2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study.2016

Author(s)

Journal Title

DOI

Data Source

[Presentation] セツキシマブに対する後天的耐性を獲得した大腸癌に対する治療法の探索2019

Author(s)

Organizer

Data Source

[Presentation] ヒト大腸癌細胞株に対するセツキシマブの効果と LDH 発現量の関係2018

Author(s)

Organizer

Data Source

[Presentation] The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma.2017

Author(s)

Organizer

Data Source

[Presentation] The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma.2017

Author(s)

Organizer

Data Source

[Presentation] Establishment of method for quantitation of antibody drugs using LC-MS/MS with biomarker analytical technique2014

Author(s)

Araki Takuya 荒木拓也

ARAKI TAKUYA 荒木拓也